Ontology highlight
ABSTRACT: Objective
To present the development of a novel upper extremity (UE) treatment and assess how it was delivered in the Critical Periods After Stroke Study (CPASS), a phase II randomized controlled trial (RCT).Design
Secondary analysis of data from the RCT.Setting
Inpatient and outpatient settings the first year after stroke.Participants
Of the 72 participants enrolled in CPASS (N=72), 53 were in the study groups eligible to receive the treatment initiated at ≤30 days (acute), 2-3 months (subacute), or ≥6 months (chronic) poststroke. Individuals were 65.1±10.5 years of age, 55% were women, and had mild to moderate UE motor capacity (Action Research Arm Test=17.2±14.3) at baseline.Intervention
The additional 20 hours of treatment began using the Activit
SUBMITTER: Barth J
PROVIDER: S-EPMC10517370 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature